Latest News- Oligonucleotide Synthesis Market: PCR primers is expected to lead the Application segment during 2025-2029
The Oligonucleotide Synthesis Market is being driven by Growing shift toward RNA-based therapeutics
The Oligonucleotide Synthesis Market is expected to grow at a CAGR of 17.4% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 4746.3 million. AI-driven algorithms are revolutionizing the oligonucleotide synthesis market by optimizing oligonucleotide design through sequence specificity, secondary structure formation, and target binding affinity analysis. These advanced algorithms leverage vast datasets to predict the most effective sequences for specific applications, expediting the design process and enhancing success rates. Furthermore, AI-powered automation platforms enable high-throughput production of custom oligonucleotides, facilitating parallel synthesis of multiple sequences in a single run. This significantly increases production capacity and scalability, enabling rapid production of large quantities of oligonucleotides for various applications, including genomics, molecular diagnostics, and therapeutics.
Get more information on Oligonucleotide Synthesis Market by requesting a sample report
Which Factors Are Causing a Surge in Market Growth?
The market is segmented based on Application (PCR primers, PCR assays and panels, DNA microarrays, Fluorescence in situ hybridization, Others) End-user (Pharmaceutical and biotechnology companies, Research and academic institutes, Diagnostic laboratories, Hospitals) Geography (North America, Europe, Asia, Rest of World (ROW)).
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Key Features in Oligonucleotide Synthesis Market Research Report
Find out which segment is leading the market by accessing the free PDF report
The Oligonucleotide Synthesis Market involves the production of short sequences of nucleotides, including those found in DNA and RNA, such as Adenine, Cytosine, Guanine, Thymine, and Uracil. This technology is essential for various applications in genetic disorders research, synthetic biology, genome projects, and therapeutic drug development. Solid-phase synthesis is a common method used for producing oligonucleotides. These chains of nucleotides, with their phosphate groups and sugar molecules (Deoxyribose for DNA, Ribose for RNA), play a crucial role in gene therapy, antisense therapy, and vector technologies. Interference RNA is another application of oligonucleotides in diseases like Cystic Fibrosis treatment.
The Oligonucleotide Synthesis Market is a significant segment of the larger global biotechnology industry, focusing on the production of custom-made single-stranded DNA or RNA molecules comprised of adenine, cytosine, guanine, and other nucleotides. This market is a subset of the broader healthcare sector, which encompasses manufacturers and providers of medical equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. The healthcare market's growth is propelled by demographic shifts, with the global population aging, leading to an increasing prevalence of genetic disorders and subsequent demand for personalized therapeutic solutions. By 2050, approximately one-quarter of the US population and Europe's population ratio is projected to be over 60 years old, necessitating significant investments in healthcare infrastructure and research and development to address the unique needs of this demographic.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
